Quality Measures for Diagnosis, Treatment and Monitoring Follow-up of Adult ADHD

Jess Bautista on January 2, 2022

ADHD CME

Quality Measures for Adult ADHD –
Diagnosis, Treatment and Monitoring Outcomes

Overview

In this webcast, Dr. Adler discusses Quality Measures for Diagnosis, Treatment and Monitoring Follow-up of Adult ADHD. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Describe the goals of Quality Measures
  • Participate in ongoing field tests of Quality Measures for ADHD upon request
  • Describe how Quality Measures are designed as measures
  • Begin implementing Quality Measures in their own practices as desired

Presented by

Lenard A. Adler, MD

Professor of Psychiatry and
Child and Adolescent Psychiatry
NYU School of Medicine
New York, New York

Course Runs: Sept 1, 2020 – Sept 1, 2021

Improving Executive Function in Adult ADHD

Jess Bautista on January 2, 2022

ADHD CME

Improving Executive Function in Adult ADHD

Overview

This 30 minute presentation with Lenard Adler, MD clarifies how the primary care practitioner can identify Executive Function Deficits in ADHD patients which are separate from symptoms of ADHD. Both the symptoms and deficits can be ameliorated with effective and very different kinds of therapy. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, you will be able to:

  • Identify potential Executive Function Deficits in patients
  • Know what symptom relief to look for in using stimulant and non-stimulant medications for ADHD patients with Executive Function Deficits
  • Refer ADHD patients with Executive Function Deficits out to appropriate types of therapy

Presented by

Lenard A. Adler, MD

Professor of Psyciatry and 
Child and Adolescent Psychiatry
Directory of the Adult ADHD Program
NYU School of Medicine
New York, New York

Course Runs: Sept 1, 2020 – Sept 1, 2021

Clinical Correlates of Working Memory Deficits in ADHD

Jess Bautista on January 2, 2022

ADHD CME

Clinical Correlates of Working Memory Deficits in ADHD

Overview

In this one-hour presentation, Joseph Biederman, MD describes they symptoms of working memory deficits as a set of Executive Function Deficits (EFDs) that can accompany ADHD and in fact have similar neural correlates in the brain. Dr. Biederman describes these phenomena throughout the lifespan, with research data in children, young adults, and adults. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Describe working memory deficits and distinguish them from ADHD symptoms
  • Identify working memory deficits in patients based on your new understanding of prevalence
  • Successfully refer ADHD patients with suspected working memory deficits to outside professional for assessment
  • Teach your patients and their families about working memory deficits in association with ADHD and raise their awareness and consideration of options

Presented by

Joseph L. Biederman, MD

Chief of the Clinical and Research Programs in
Pediatric Psychopharmacology and Adult ADHD
Massachusetts General Hospital

Professor of Psychiatry
Harvard Medical School
Boston, Massachusetts

Course Runs: Sept 1, 2020 – Sept 1, 2021

ADHD and Substance Use Disorders SUD

Jess Bautista on January 2, 2022

ADHD CME

ADHD and Substance Use Disorder

Overview

In this 66-minute presentation, Anthony Rostain, MD, MA clearly describes the neural correlates that ADHD patients share with proclivity toward substance abuse. He reviews the risks of Substance Use Disorder (SUD) in teenagers, college students, and adults, discusses appropriate medication usage, and describes multiple treatment approaches (both pharmaceutical and cognitive therapies) that clinicians can use to treat both ADHD and SUD. A trusting clinician-patient relationship is an important key to treatment success. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to describe:

  • The prevalence, phenomenology and impact of Substance Use Disorders in youth and adults with ADHD
  • Current theories regarding the links between ADHD and SUD
  • Key studies documenting the occurrence of stimulant misuse and abuse among college and university students
  • Clinical strategies for managing ADHD in the presence of SUD and for reducing the misuse/abuse of stimulant medications in at-risk patients

Presented by

Anthony L. Rostain, MD, MA

Professor of Psychiatry and Pediatrics
University of Pennsylvania and Perelman School of Medicine

Medical Director, Adult ADHD Treatment & Research Program
PENN Behavioral Health, University of Pennsylvania Health System
Philadelphia, Pennsylvania

Course Runs: Sept 1, 2020 – Sept 1, 2021

Using the ASRS to Monitor Treatment

Jess Bautista on January 2, 2022

ADHD CME

Using the ASRS as a Measure of ADHD Treatment Response

Overview

In this webcast, Dr. Rostain describes using the ASRS to monitor treatment response

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Use the ASRS screener and 18 Symptom checklist for adult ADHD to monitor patients response to medication treatment
  • Recommend skills classes for patients in addition to medication
  • Use the 18 Symptom checklist to evaluate medication efficacy, symptom reduction, and need for medication adjustments

Presented by

Anthony L. Rostain, MD, MA

Professor of Psychiatry and Pediatrics
University of Pennsylvania Perelman School of Medicine

Medical Director, Adult ADHD Treatment & Research Program
PENN Behavioral Health, University of Pennsylvania Health System
Philadelphia, Pennsylvania

Course Runs: Sept 1, 2020 – Sept 1, 2021

Using the ASRS in Practice

Jess Bautista on January 2, 2022

ADHD CME

Using the New ASRS Screener in Clinical Practice

Overview

The ASRS-5 online screener, which conforms with DSM-5, can be used effectively in the office as a quick screen for potential diagnosis of ADHD. Dr. Rostain discusses prompts for use of the screener, use of the screener itself, and next steps in making a complete diagnosis. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Use the ASRS to screen for adult ADHD in the practice office
  • Be able to score the screener and determine a positive vs negative screen
  • Conduct a complete diagnosis of ADHD following a positive screen
  • Train office personnel to administer and score a screener for adult ADHD

Presented by

Anthony L. Rostain, MD, MA

Professor of Psychiatry and Pediatrics
University of Pennsylvania Perelman School of Medicine

Medical Director, Adult ADHD Treatment & Research Program
PENN Behavioral Health, University of Pennsylvania Health System
Philadelphia, Pennsylvania

Course Runs: Sept 1, 2020 – Sept 1, 2021

Managing ADHD Medications in Outpatient Settings: A Guide for Primary Care Providers

Jess Bautista on January 2, 2022

ADHD CME

Managing ADHD Medications in Outpatient Settings:
A Guide for Primary Care Providers

Overview

Anthony Rostain, MD discusses the ongoing management of ADHD medications as primary care providers and patients work together to find the most effective medication and dosage. There is a variety of medications to be considered, along with consideration of comorbidities. Dr. Rostain offers a clear evidence-based guide. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Discuss strategies for follow-up care of adults with ADHD
  • Monitor clinical outcomes and adverse effects
  • Titrate medications to achieve optimal improvement
  • Improve patient adherence
  • Address common misconceptions

Presented by

Anthony L. Rostain, MD, MA

Professor of Psychiatry and Pediatrics
University of Pennsylvania Perelman School of Medicine

Medical Director, Adult ADHD Treatment & Research Program
PENN Behavioral Health, University of Pennsylvania Health System
Philadelphia, Pennsylvania

Course Runs: Sept 1, 2020 – Sept 1, 2021

Cardiovascular Safety of ADHD Medication Treatments

Jess Bautista on January 2, 2022

ADHD CME

Cardiovascular Safety of ADHD Medication Treatments

Overview

In this session, Dr. Rostain discusses the considerations primary care practitioners should make when working with ADHD patients and stimulant medications. Cardiovascular safety should be assessed. If a patient has cardiovascular issues, Dr. Rostain lays out clearly the protocol to be followed. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Screen for cardiovascular risk before prescribing ADHD medications
  • Discuss with your patients the medication alternatives in treating ADHD
  • Monitor your patients safely when prescribing ADHD medications
  • Refer ADHD patients out to cardiology when cardiovascular risk is identified

Presented by

Anthony L. Rostain, MD, MA

Professor of Psychiatry and Pediatrics
University of Pennsylvania Perelman School of Medicine

Medical Director, Adult ADHD Treatment & Research Program
PENN Behavioral Health, University of Pennsylvania Health System
Philadelphia, Pennsylvania

Course Runs: Sept 1, 2020 – Sept 1, 2021

Comorbid and Reverse Comorbid Bipolar Disorder and ADHD

Jess Bautista on January 2, 2022

ADHD CME

More than the sum of its parts:
Comorbid and Reverse Comorbid Bipolar Disorder and ADHD

Overview

In this webcast, Dr. Nierenberg describes different major networks in the brain and their function; discusses diagnosis of dysregulations in ADHD and bipolar patients; identifies appropriate medications for ADHD and Bipolar Disorder; and explains the switching problems that patients may have among brain modes.

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Describe different major networks in the brain and their function
  • Recognize and diagnose dysregulations in ADHD and bipolar patients 
  • Prescribe appropriate medications for ADHD and Bipolar Disorder
  • Explain to patients the switching problems they have among brain modes

Presented by

Andrew A. Nierenberg, MD

Thomas P. Hackett Endowed Chair in Psychiatry at MGH

Dauten Family Center for Bipolar Treatment Innovation
Massachusetts General Hospital

Professor of Psychiatry
Harvard Medical School

Course Runs: Sept 1, 2020 – Sept 1, 2021

Mindfulness-Based Therapy for Adults with ADHD Part 2

Jess Bautista on January 2, 2022

ADHD CME

Mindfulness-Based Therapy for Adults with ADHD – Part 2

Overview

In this continued 50 minute presentation by John Mitchell, PhD, we go through the learning modules (3-8) of a sample Mindfulness program for ADHD, with modules focusing on; breath, body and sound, body sensations, thoughts, judgements, emotions, and interactions with others. (Modules 1-2 are covered in part 1) 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME activity, you will be able to:

  • Describe the components of an evidence-based Mindfulness program for ADHD patients
  • Discuss Mindfulness with your ADHD patients as an option for care, and refer them to effective programs
  • Choose to begin your own Mindfulness practice from available resources to assist ADHD patients via direct training

Presented by

John Mitchell, Ph.D.

Assistant Professor
Department of Psychiatry & Behavioral Sciences
Duke University Medical center
Duke ADHD Program
Durham, North Carolina

Course Runs: Sept 1, 2020 – Sept 1, 2021

Assessing Functional Outcomes in Young Adults with ADHD

Jess Bautista on January 2, 2022

ADHD CME

Assessing Functional Outcomes in Young Adults with ADHD

Overview

This 27-minute presentation with Lenard Adler, MD explains the components of a complete diagnosis and ADHD in adults and how to distinguish the symptoms of ADHD from frequently comorbid executive function deficits.

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Explain the components of a complete diagnosis of ADHD in adults
  • Recognize the symptoms of ADHD and executive function impairment in your patients.
  • Use the quality of life indicators to screen for ADHD in adults
  • Be prompted to screen your patients for ADHD form comorbid disorders

Presented by

Lenard A. Adler, MD

Professor of Psychiatry and 
Child and Adolescent Psychiatry
Director of the Adult ADHD Program 
NYU School of Medicine 
New York, New York

Course Runs: Sept 1, 2020 – Sept 1, 2021

Best Practices for Treating and Monitoring ADHD

Jess Bautista on January 2, 2022

ADHD CME

Best Practices for Treating and Monitoring ADHD

Overview

In this webcast, Dr. Adler discusses best practices for treating and monitoring ADHD in adults. 

This webcast was recorded live and is being used with permission by the presenter.

Completing this course will help you:

  • List commonly used medications for adult ADHD
  • Begin treating an ADHD patient with proper dose of a chosen medication
  • Discuss with patients the Executive Function Deficits that accompany ADHD symptoms
  • Advise ADHD patients of the risk of diversion of medications
  • Discuss with patients the common side effects of ADHD medications and suggest work-arounds

PRESENTED BY

Lenard A. Adler, MD

Professor of Psychiatry and
Child and  Adolescent Psychiatry
Director Adult ADHD Program
NYU School of Medicine
New York, New York

Course Runs: Sept 1, 2020 – Sept 1, 2021

Mindfulness-Based Therapy for Adults with ADHD Part 1

Jess Bautista on January 2, 2022

ADHD CME

Mindfulness-Based Therapy for Adults with ADHD – Part 1

Overview

In the 65-minute presentation by John Mitchell, Ph.D., you will learn the history of overall Behavior Therapy and the more specific development of Mindfulness-Based Therapy (MBT) for ADHD and other conditions. You will learn the evidence basis for the efficacy of MBT as a legitimate treatment choice in your toolkit for ADHD, derived from previous research. You will be exposed to the overall approach in introducing MBT to your ADHD patients, whether you choose to refer them to third-party programs or begin to deliver all or portions of this program yourself. 

This webcast was recorded live and is being used with the permission of the presenter.

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Describe the evolution of Mindfulness-Based Therapy (MBT) in waves of development in overall Behavior Therapy 
  • Share the evidence-basis and efficacy of MNT with fellow clinicians and patients
  • Describe an MBT program to your ADHD patients, how it can help them, and refer them to outside programs as an adjunct to therapies used in your practice

Presented by

John Mitchell, Ph.D.

Assistant Professor
Department of Psychiatry & Behavioral Sciences
Duke University Medical Center
Duke ADHD Program
Durham, North Carolina

Course Runs: Sept 1, 2020 – Sept 1, 2021

Making the Diagnosis and Optimizing Treatment Part 2 – Optimizing Treatment

Jess Bautista on January 2, 2022

ADHD CME

ADHD in Adults: Making the Diagnosis and Optimizing Treatment
Part 2: Optimizing Treatment

Overview

In this second of a two-part series on Diagnosing and Optimizing Treatment for ADHD, primary care clinicians will learn to choose and dose ADHD medications appropriately for symptom improvement, determine improvement levels through Measurement-Based Care, recognize side effects that would warrant medication change or adjustment, and refer patients appropriately for psycho-social support. Presented by a family physician who diagnoses and treats ADHD full-time, learners will walk away with a confidence in handling ADHD as we currently do anxiety, depression, and associated medications.

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Choose confidently between stimulant and non-stimulant medication for a particular patient
  • Titrate medication dosage up to an optimal level in each patient over an appropriate time period
  • Refer to a third party for adjunctive and appropriate psycho-social support
  • Follow and ADHD patient’s improvement with Measurement-Based Care
  • Identify adverse side effects of medication that would warrant a change to a different medication

Presented by

Oren Mason, MD

Principal, Attention MD

Assistant Professor
Michigan State University
College of Human Medicine
Grand Rapids, Michigan

Making the Diagnosis and Optimizing Treatment Part 1 – Making the Diagnosis

Jess Bautista on January 2, 2022

ADHD CME

ADHD in Adults: Making the Diagnosis and Optimizing Treatment
Part 1: Making the Diagnosis

Overview

In this first of a two-part series on Diagnosing and Optimizing Treatment for ADHD, primary care clinicians will learn the appropriate prompts for ADHD screening, how to make a complete ADHD diagnosis and how to schedule and monitor the prescription of medication for ADHD symptom relief. Presented by a family physician who diagnoses and treats ADHD full-time, learners will walk away with confidence in handling ADHD as we currently do anxiety, depression, and associated medications. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Make available the 6-question ASRS screener for your offie patients, and know what next steps to take when someone screens positive for ADHD
  • Use the ADH 18 symptom checklist and other prescribed methods for making a complete and thorough diagnosis of ADHD
  • Know what comorbid conditions patients might have that can trigger a screen for underlying ADHD
  • Prescribe medications for and ADHD trial treatment with confidence, and how to titrate those medications up to effective dosing.
  • Set up an effective patient visit schedule to diagnose, treat and monitor ADHD in patients. 

Presented by

Oren Mason, MD

Principal, Attention MD

Assistant Professor
Michigan State University
College of Human Medicine
Grand Rapids, Michigan

ADHD and Women Part 2 – Differences in Treatment

Jess Bautista on January 2, 2022

ADHD CME

Women and ADHD: Differences in Treatment

Overview

In this second of a two-part series on ADHD and Women, Ellen Littman, PhD discusses the unique situations of ADHD women with high IQs and those with hyperactive/impulsive presentation. The majority of the session focuses on the variety of successful therapeutic options for all women with ADHD.

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Successfully identify ADHD women with high IQs and hyperactive/impulsive type for diagnosis and care
  • Support ADHD women in the primary care setting to communicate directly and self-advocate for optimal medical care.
  • Recommend psychotherapeutic treatments and make referrals to qualified local professionals
  • Identify comorbid disorders that are common to ADHD women, and take steps to treat the disorder along with the underlying ADHD

Presented by

Ellen Littman, PhD

Clinical Therapist in Priivate Practice
Mt. Kisco, New York

Course Runs: Sept 1, 2020 – Sept 1, 2021

ADHD and Women Part 1 – Differences in Diagnosis

Jess Bautista on January 2, 2022

ADHD CME

Women and ADHD: Differences in Screening

Overview

In this first of a two-part series on ADHD and Women, Ellen Littman, PhD describes the significant difference in symptoms of ADHD in women vs. men. Because diagnostic criteria for ADHD were developed in the early 1900s based upon the symptoms of hyperactive boys, many young females and even older women have been missed in diagnosis. We now know what to look for in women with ADHD, and Part 1 provides that clarity for screening and diagnosis.

This webcast was recorded live and is being used with the permission of the presenter.

at the conclusion of this course you will be able to:

  • Interview women patients for chronic health complaints that can signal underlying ADHD
  • Differentiate ADHD symptoms to look for in female vs male patients
  •  Reduce misdiagnosis of anxiety and depression in women, and query further about underlying ADHD.
  • Recognize hormonal and emotional dysregulation cycles, isolated social life, and CNS hyper-sensitivities as potentials for ADHD screening. 

PRESENTED BY

Ellen Littman, PhD

Clinical Therapist in Private Practice
Mt. Kisco, New York

Course Runs: Sept 1, 2020 – Sept 1, 2021

Altering the Long-Term Trajectory of ADHD

Jess Bautista on January 2, 2022

ADHD CME

Can We Alter Trajectories to Improve Long-Term Outcomes in ADHD?

Overview

In this 51-minute presentation, Jeffrey Halperin, PhD describes the development of ADHD symptoms throughout the lifespan, what we know about the interplay between environment and genetics, and how the environment can be used to alter long-term trajectory of ADHD, evidenced by reduced symptomatology. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to describe:

  • The best time to detect and treat ADHD
  • The interplay between genetics and the environment in the development of ADHD symptoms
  • Brain development and its relationship to ADHD
  • The role of games and exercises in improving ADHD symptomatology

Presented by

Jeffrey M. Halperin, PhD

Distinguished Professor
Department of Psychology
Queens College, City University of New York

Department of Psychiatry
The Mount Sanai School of Medicine 
Queens, New York

Course Runs: Sept 1, 2020 – Sept 1, 2021

Integrating Pharmacologic and Alternative Treatments for ADHD

Jess Bautista on January 2, 2022

ADHD CME

Integrating Pharmacologic and Non-pharmacologic Treatments:
An Evidence-Based Approach

Overview

In this 40 minute presentation, Dr. Stephen Faraone, PhD presents the appropriate use of both pharmacologic and non-pharmacologic treatments for ADHD individuals. Non-pharmacologic treatments include cognitive training, meditation, diet inclusions and restrictions, and more. Dr. Faraone uses an evidence-based approach which evaluates the quality of evidence and magnitude of treatment effect (effect size) for each therapy. Further, treatments are categorized into broadband (treating many symptoms) vs narrow band (treating specific issues), and presents a helpful algorithm for healthcare providers to follow inn combining broadband/narrow band as well as pharmacologic/non-pharmacologicc therapies based on patients response and folow-up.

This webcast was recorded live and is being used with the permission of the presenter.

At he conclusion of this presentation, participants will be able to:

  • Describe the multiplicity of treatment options of ADHD symptoms and related impairments frequently comorbid with ADHD
  • Choose treatment options based upon their quality of evidence and effect size and the interests of your patient
  • Use an algorithm described in the session to plot a course of treatment for ADHD patients based upon reported and observed symptoms
  • Access further ADHD CME resources on the http://adhdinadults.com website to learn further detail about both medication and non-pharmacologic interventions

Presented by

Stephen V. Faraone PhD

Distinguished Professor
Departments of Psychiatry and
Neuroscience and Physiology
SUNY Upstate Medical University

President, World Federation of ADHD

Late Onset and Atypical Forms of ADHD

Jess Bautista on January 2, 2022

ADHD CME

Late Onset and Atypical Forms of Attention Deficit Hyperactivity Disorder

Overview

In this 50 minute presentation, Stephen V. Faraone, PhD presents atypical cases of ADHD which can confound diagnosis in the clinical setting. Clinical guidance is given in clarifying how to diagnose ADHD with late onset beyond the DSM-5 age of 12, as well as individuals with both low and high IQ who may also have ADHD. 

This webcast was recorded live and is being used with the permission of the presenter. 

At the conclusion of this CME Activity, primary healthcare professionals will be able to:

  • Separate the symptoms of intellectual disability and low IQ from symptoms of ADHD, in order to make an ADHD diagnosis
  • Identify significant impairments in high IQ that may lead to an ADHD diagnosis despite their intelligence
  • Diagnose young adults with ADHD whose symptoms may have developed or become more severe at ages older than the DSM-5 criterion of age 12

Presented by

Stephen V. Faraone, PhD

Distinguished Professor
Departments of Psychiatry and 
Neuroscience and Physiology
SUNY Upstate Medical University

President, World Federation of ADHD

Course Runs: Sept 1, 2020 – Sept 1, 2021